8 studies found for:    ASUBIO
Show Display Options
Rank Status Study
1 Withdrawn Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke
Condition: Stroke
Intervention: Drug: SUN13837
2 Completed A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: ASB17061;   Drug: Placebo
3 Completed Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)
Condition: Acute Spinal Cord Injury
Interventions: Drug: SUN13837 injection;   Drug: Placebo
4 Completed Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke
Conditions: Nonhemorrhagic Ischemic Stroke;   Motor Function
5 Completed A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: SUN13834;   Drug: Placebo
6 Completed SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Cachexia
Interventions: Drug: Placebo comparator;   Drug: SUN11031
7 Completed Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: piclozotan;   Drug: 0.9% sodium chloride (normal saline)
8 Terminated Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)
Condition: Stroke
Interventions: Drug: piclozotan low dose;   Drug: placebo;   Drug: piclozotan  high dose

Indicates status has not been verified in more than two years